CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Liver Diseases · Liver Cancer · Liver Cirrhosis · Liver Failure · Liver Metastases · Liver Transplant Rejection · Liver Steatoses

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Health Science Center (PKUHSC), Beijing, Changping, China
Contact: Study coordinator (Huan Yang, Phd) · PAD@aotcri.org · +8613202512868

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Liver Metastases · Colorectal Cancer · Anal Canal Cancer

Abroad (travel likely)RecruitingPHASE2

São Paulo, Brazil

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Colorectal Cancer · Liver Metastases

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Copper Supplementation in Cirrhosis

Cirrhosis · Chronic Liver Disease · Fibrosis

Abroad (travel likely)Recruiting

Seattle, United States

Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

Alcohol-related Liver Disease · Liver Diseases

Abroad (travel likely)Recruiting

Detroit, United States